OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3020% below fair value
$1.68+0.01 (+0.60%)
Close on Nov 13, 2026Market cap $1.25BP/E –Yield –
OPKO Health operating margin
Operating margin is operating income as a percentage of revenue.
OPKO Health's operating margin for the twelve months ending Sep 30, 2026 was -17.5%. For fiscal 2025 it was -19.3%, against -21.3% the year before. The highest annual figure on record is 4.0% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -19.3% | +2.0 |
| FY2024 | Dec 31, 2024 | -21.3% | −3.1 |
| FY2023 | Dec 31, 2023 | -18.2% | +4.3 |
| FY2022 | Dec 31, 2022 | -22.5% | −23.6 |
| FY2021 | Dec 31, 2021 | 1.1% | −3.0 |
| FY2020 | Dec 31, 2020 | 4.0% | +34.4 |
| FY2019 | Dec 31, 2019 | -30.4% | −13.1 |
| FY2018 | Dec 31, 2018 | -17.3% | +11.3 |
| FY2017 | Dec 31, 2017 | -28.6% | −20.0 |
| FY2016 | Dec 31, 2016 | -8.6% | +11.4 |
| FY2015 | Dec 31, 2015 | -20.0% | +140.0 |
| FY2014 | Dec 31, 2014 | -160.0% | −77.5 |
| FY2013 | Dec 31, 2013 | -82.5% | −3.3 |
| FY2012 | Dec 31, 2012 | -79.2% | +3.7 |
| FY2011 | Dec 31, 2011 | -82.9% | −43.8 |
| FY2010 | Dec 31, 2010 | -39.1% | +462.2 |
| FY2009 | Dec 31, 2009 | -501.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -48.0% | +11.5 |
| Q2 FY2026 | Jun 30, 2026 | -4.3% | +34.0 |
| Q1 FY2026 | Mar 31, 2026 | -41.1% | +3.7 |
| Q4 FY2025 | Dec 31, 2025 | 1.0% | +19.1 |
| Q3 FY2025 | Sep 30, 2025 | -59.5% | −20.8 |
| Q2 FY2025 | Jun 30, 2025 | -38.3% | −4.4 |
| Q1 FY2025 | Mar 31, 2025 | -44.8% | −3.6 |
| Q4 FY2024 | Dec 31, 2024 | -18.0% | +19.9 |
| Q3 FY2024 | Sep 30, 2024 | -38.7% | −2.6 |
| Q2 FY2024 | Jun 30, 2024 | -33.9% | −36.5 |
| Q1 FY2024 | Mar 31, 2024 | -41.2% | −28.3 |
| Q4 FY2023 | Dec 31, 2023 | -38.0% | −8.1 |
| Q3 FY2023 | Sep 30, 2023 | -36.1% | +12.8 |
| Q2 FY2023 | Jun 30, 2023 | 2.6% | +6.1 |
| Q1 FY2023 | Mar 31, 2023 | -12.9% | +9.1 |
| Q4 FY2022 | Dec 31, 2022 | -29.8% | −14.1 |
| Q3 FY2022 | Sep 30, 2022 | -48.9% | −58.7 |
| Q2 FY2022 | Jun 30, 2022 | -3.5% | −4.7 |
| Q1 FY2022 | Mar 31, 2022 | -22.0% | −29.0 |
| Q4 FY2021 | Dec 31, 2021 | -15.7% | −25.7 |
| Q3 FY2021 | Sep 30, 2021 | 9.8% | +4.7 |
| Q2 FY2021 | Jun 30, 2021 | 1.3% | −7.8 |
| Q1 FY2021 | Mar 31, 2021 | 7.1% | +26.3 |
| Q4 FY2020 | Dec 31, 2020 | 10.0% | +60.1 |
| Q3 FY2020 | Sep 30, 2020 | 5.1% | +22.2 |
| Q2 FY2020 | Jun 30, 2020 | 9.0% | +29.9 |
| Q1 FY2020 | Mar 31, 2020 | -19.3% | +14.6 |
| Q4 FY2019 | Dec 31, 2019 | -50.1% | −9.6 |
| Q3 FY2019 | Sep 30, 2019 | -17.1% | −3.7 |
| Q2 FY2019 | Jun 30, 2019 | -20.9% | −18.9 |
| Q1 FY2019 | Mar 31, 2019 | -33.9% | −17.1 |
| Q4 FY2018 | Dec 31, 2018 | -40.6% | +57.3 |
| Q3 FY2018 | Sep 30, 2018 | -13.4% | +6.0 |
| Q2 FY2018 | Jun 30, 2018 | -1.9% | +6.9 |
| Q1 FY2018 | Mar 31, 2018 | -16.7% | +0.3 |
| Q4 FY2017 | Dec 31, 2017 | -97.9% | −71.2 |
| Q3 FY2017 | Sep 30, 2017 | -19.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -8.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -17.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -26.7% | – |
See a number that looks wrong?